Literature DB >> 29354360

Human leukocyte antigen (HLA-F) polymorphism is associated with chronic HBV infection.

Ahmed Baligh Laaribi1,2,3, Naila Hannachi2, Hamza Ben Yahia1, Manal Marzouk2, Asma Mehri2,3, Manel Belhadj2, Salwa Yacoub4, Amel Letaief5, Hadda-Imene Ouzari1, Abdellatif Boudabous1, Jalel Boukadida2, Roberta Rizzo6, Inès Zidi1.   

Abstract

Human leukocyte antigen (HLA)-F has been involved in immune regulation of infectious diseases. However, the role of HLA-F polymorphisms in hepatitis B infection outcomes remains unclear. Here, we aimed to determine HLA-F polymorphism implication in chronic HBV. Genotype analysis was performed for three single nucleotide polymorphisms (SNPs) of HLA-F and one SNP of HLA-E using PCR-SSP, in 252 Tunisian patients with chronic HBV infection stratified according to their HBV DNA levels (140 patients with low HBV DNA levels < 2000 IU/mL and 112 patients with high HBV DNA levels ≥ 2000 IU/mL) and 240 healthy controls (CTRL). The three HLA-F SNPs (HLA-F*01:02, -F*01:03 and -F*01:04) have the same allelic and genotypic frequencies in patients and in CTRL. We reported a low HLA-F*01:02 and F*01:04 allelic frequencies in the Tunisian population; however, high HLA-F*01:03 allele frequencies were observed (17%). A significant association was found between the HLA-F*01:03 allele and decreased level of HBV DNA (P = 0.02 OR 0.56, 95% CI 0.35-0.92). No significant differences were observed in haplotype distribution between patients and CTRL. A significant association of HLA-F*01:03 with the level of HBV DNA suggests an important role of HLA-F in HBV replication control.

Entities:  

Keywords:  Chronic hepatitis; Fibrosis; Hepatitis B virus; Human leukocyte antigen-F; Single nucleotide polymorphism

Year:  2018        PMID: 29354360      PMCID: PMC5752667          DOI: 10.1007/s13205-017-1079-9

Source DB:  PubMed          Journal:  3 Biotech        ISSN: 2190-5738            Impact factor:   2.406


  26 in total

Review 1.  Expression of nonclassical MHC class Ib genes: comparison of regulatory elements.

Authors:  T Kevin Howcroft; Dinah S Singer
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

2.  HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C.

Authors:  V M Braud; D S Allan; C A O'Callaghan; K Söderström; A D'Andrea; G S Ogg; S Lazetic; N T Young; J I Bell; J H Phillips; L L Lanier; A J McMichael
Journal:  Nature       Date:  1998-02-19       Impact factor: 49.962

3.  Association between sHLA-G and HLA-G 14-bp deletion/insertion polymorphism in Crohn's disease.

Authors:  Inès Zidi; Hamza Ben Yahia; Daria Bortolotti; Leila Mouelhi; Ahmed Baligh Laaribi; Shema Ayadi; Nour Zidi; Fatma Houissa; Radhouane Debbech; Abdellatif Boudabous; Taoufik Najjar; Dario Di Luca; Roberta Rizzo
Journal:  Int Immunol       Date:  2015-01-10       Impact factor: 4.823

4.  HLA-G may predict the disease course in patients with early rheumatoid arthritis.

Authors:  Roberta Rizzo; Ilaria Farina; Daria Bortolotti; Elisa Galuppi; Antonella Rotola; Loredana Melchiorri; Giovanni Ciancio; Dario Di Luca; Marcello Govoni
Journal:  Hum Immunol       Date:  2012-12-08       Impact factor: 2.850

5.  Association of HLA-E polymorphism with severe bacterial infection and early transplant-related mortality in matched unrelated bone marrow transplantation.

Authors:  Ryad Tamouza; Vanderson Rocha; Marc Busson; Catherine Fortier; Sherif M El Sherbini; Hélène Esperou; Alain Filion; Gérard Socié; Nicolas Dulphy; Rajagopal Krishnamoorthy; Antoine Toubert; Eliane Gluckman; Dominique Charron
Journal:  Transplantation       Date:  2005-07-15       Impact factor: 4.939

6.  Age, gender, and local geographic variations of viral etiology of hepatocellular carcinoma in a hyperendemic area for hepatitis B virus infection.

Authors:  C M Lee; S N Lu; C S Changchien; C T Yeh; T T Hsu; J H Tang; J H Wang; D Y Lin; C L Chen; W J Chen
Journal:  Cancer       Date:  1999-10-01       Impact factor: 6.860

Review 7.  Hepatitis B virus immunopathogenesis.

Authors:  F V Chisari; C Ferrari
Journal:  Annu Rev Immunol       Date:  1995       Impact factor: 28.527

Review 8.  Human genetic susceptibility to infectious disease.

Authors:  Stephen J Chapman; Adrian V S Hill
Journal:  Nat Rev Genet       Date:  2012-02-07       Impact factor: 53.242

9.  Cytotoxic T lymphocytes recognize an HLA-A2-restricted epitope within the hepatitis B virus nucleocapsid antigen.

Authors:  A Penna; F V Chisari; A Bertoletti; G Missale; P Fowler; T Giuberti; F Fiaccadori; C Ferrari
Journal:  J Exp Med       Date:  1991-12-01       Impact factor: 14.307

10.  Lesion human leukocyte antigen-F expression is associated with a poor prognosis in patients with hepatocellular carcinoma.

Authors:  Yongfu Xu; Haixiong Han; Fabiao Zhang; Shangdong Lv; Zhengyu Li; Zheping Fang
Journal:  Oncol Lett       Date:  2014-11-07       Impact factor: 2.967

View more
  5 in total

1.  Insights into the Interplay between KIR Gene Frequencies and Chronic HBV Infection in Burkina Faso.

Authors:  Pegdwendé Abel Sorgho; Jeremy James Martinson; Florencia Wendkuuni Djigma; Albert Théophane Yonli; Bolni Marius Nagalo; Tegwinde Rebeca Compaore; Dorcas Obiri-Yeboah; Birama Diarra; Herman Karim Sombie; Arsène Wendpagnangdé Zongo; Abdoul Karim Ouattara; Serge Théophile R Soubeiga; Lassina Traore; Lewis R Roberts; Jacques Simpore
Journal:  Mediterr J Hematol Infect Dis       Date:  2018-11-01       Impact factor: 2.576

Review 2.  The Emerging Roles of Human Leukocyte Antigen-F in Immune Modulation and Viral Infection.

Authors:  Aifen Lin; Wei-Hua Yan
Journal:  Front Immunol       Date:  2019-05-10       Impact factor: 7.561

3.  Evolution of HLA-F and its orthologues in primate species: a complex tale of conservation, diversification and inactivation.

Authors:  N Otting; N G de Groot; R E Bontrop
Journal:  Immunogenetics       Date:  2020-11-12       Impact factor: 2.846

4.  Targeting HLA-F suppresses the proliferation of glioma cells via a reduction in hexokinase 2-dependent glycolysis.

Authors:  Xin Chen; Na Sun; Rongqin Li; Xuejia Sang; Xueqin Li; Jie Zhao; Jing Han; Jing Yang; Takayuki Ikezoe
Journal:  Int J Biol Sci       Date:  2021-03-25       Impact factor: 6.580

5.  HLA-F Allele-Specific Peptide Restriction Represents an Exceptional Proteomic Footprint.

Authors:  Gia-Gia T Hò; Funmilola J Heinen; Rainer Blasczyk; Andreas Pich; Christina Bade-Doeding
Journal:  Int J Mol Sci       Date:  2019-11-08       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.